Curis Issued U.S. Patent Covering Hedgehog Pathway Agonists.
Business Wire › October 04, 2006
Linked as:
Extract
Curis Issued U.S. Patent Covering Hedgehog Pathway Agonists.
CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, today announced that it has been issued U.S. patent 7,115,653, entitled "Small Organic Molecule Regulators of Cell Proliferation." The claims of this patent cover specific small molecule compounds tha...
See the full content of this document
Sponsored links
